Literature DB >> 6703926

Reassessment of criteria for the selection of perfluorochemicals for second-generation blood substitutes: analysis of structure/property relationships.

J G Riess.   

Abstract

The criteria for the selection of perfluorochemicals destined to serve as oxygen carriers in second-generation blood substitutes are critically discussed in light of the presently available body of data. The need for pure, well-defined, reproducible, industrially feasible perfluorochemicals, in order to attain the degree of reliability desirable for their use in medicine, is stressed. Particular attention is given to the inverse excretion rate versus emulsion stability relationship and to its sharp dependence on molecular weight. The range of acceptable molecular weights is established as 460-520. Oxygen-dissolving capacity, rheologic characteristics, and intravascular persistence are also discussed. The need for standard methodology and experimental protocols is reaffirmed. Perspectives are evaluated, in particular, with the aim of easing certain of the present limitations.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6703926     DOI: 10.1111/j.1525-1594.1984.tb04243.x

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  9 in total

1.  Quantification of vascular damage in acute kidney injury with fluorine magnetic resonance imaging and spectroscopy.

Authors:  Jeremy K Moore; Junjie Chen; Hua Pan; Joseph P Gaut; Sanjay Jain; Samuel A Wickline
Journal:  Magn Reson Med       Date:  2017-11-16       Impact factor: 4.668

2.  Biodistribution of mixed fluorocarbon-hydrocarbon dowel molecules used as stabilizers of fluorocarbon emulsions: a quantitative study by fluorine nuclear magnetic resonance (NMR).

Authors:  L Zarif; M Postel; B Septe; L Trevino; J G Riess; A M Mahé; R Follana
Journal:  Pharm Res       Date:  1994-01       Impact factor: 4.200

3.  A new concentrated perfluorochemical emulsion and carbogen breathing as an adjuvant to treatment with antitumor alkylating agents.

Authors:  B A Teicher; S A Holden; G Ara; C S Ha; T S Herman; D Northey
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

4.  Half life and changes in the composition of a perfluorochemical emulsion within the vascular system of rats.

Authors:  J Lutz; M Stark
Journal:  Pflugers Arch       Date:  1987-09       Impact factor: 3.657

5.  Reduced oxygenation in a rat mammary carcinoma after chemo- or radiation therapy and reoxygenation with perflubron emulsion/carbogen breathing.

Authors:  B A Teicher; E A Sotomayor; N P Dupuis; T Kusumoto; K Menon
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

6.  Potentiation of cytotoxic therapies by TNP-470 and minocycline in mice bearing EMT-6 mammary carcinoma.

Authors:  B A Teicher; S A Holden; N P Dupuis; Y Kakeji; M Ikebe; Y Emi; D Goff
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

7.  Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth.

Authors:  Neelesh R Soman; Steven L Baldwin; Grace Hu; Jon N Marsh; Gregory M Lanza; John E Heuser; Jeffrey M Arbeit; Samuel A Wickline; Paul H Schlesinger
Journal:  J Clin Invest       Date:  2009-08-10       Impact factor: 14.808

8.  Use of Lymphoblastoid Namalva Cell Cultures in a Toxicity Test. Application to the Monitoring of Detoxification Procedures for Fluorocarbons to be used as Intravascular Oxygen-Carriers.

Authors:  M Le Blanc; J G Riess; D Poggi; R Follana
Journal:  Pharm Res       Date:  1985-09       Impact factor: 4.200

Review 9.  Application of Light Scattering Techniques to Nanoparticle Characterization and Development.

Authors:  Patrícia M Carvalho; Mário R Felício; Nuno C Santos; Sónia Gonçalves; Marco M Domingues
Journal:  Front Chem       Date:  2018-06-25       Impact factor: 5.221

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.